UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden

hours per response:

0.5

1. Name and Address of Reporting Person*YOUNG JOHN D

(Last)

(First)

(Middle)

PFIZER INC.-CORP. SECRETARY

235 EAST 42ND ST.

(Street)

NEW YORK

NY

10017

(City)

(State)

(Zip)

2. Date of Event Requiring Statement

(Month/Day/Year)

06/01/2012

3. Issuer Name and Ticker or Trading Symbol

PFIZER INC

[ PFE ]

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

Director

10% Owner

Officer (give title below)

Other (specify below)

Business Unit President

5. If Amendment, Date of Original Filed

(Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr.

4)

2.

Amount of Securities Beneficially Owned (Instr.

4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

4. Nature of Indirect Beneficial Ownership (Instr.

5)

Common Stock

66,539

Common Stock

1,215

By Trustee under the Pfizer Share Ownership Plan

Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr.

4)

2. Date Exercisable and Expiration Date

(Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr.

4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

6. Nature of Indirect Beneficial Ownership (Instr.

5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option (right to buy)

(1)

02/21/2017

Common Stock

41,700

$25.87

Employee Stock Option (right to buy)

(1)

02/22/2016

Common Stock

31,500

$26.2

Employee Stock Option (right to buy)

(1)

02/23/2015

Common Stock

21,600

$26.2

Employee Stock Option (right to buy)

(1)

02/26/2013

Common Stock

22,950

$29.33

Employee Stock Option (right to buy)

(1)

02/25/2014

Common Stock

29,300

$37.15

Stock Appreciation Rights

02/26/2014(2)

02/26/2014(2)

Common Stock

39,677

$12.7

Stock Appreciation Rights

02/25/2015(2)

02/25/2015(2)

Common Stock

49,364

$17.69

Stock Appreciation Rights

12/31/2014(2)

12/31/2014(2)

Common Stock

26,767

$18.19

Stock Appreciation Rights

02/24/2016(2)

02/24/2016(2)

Common Stock

52,570

$18.9

Stock Appreciation Rights

02/24/2018(3)

02/24/2018(3)

Common Stock

43,520

$18.9

Stock Appreciation Rights

02/23/2017(2)

02/23/2017(2)

Common Stock

51,578

$21.03

Stock Appreciation Rights

02/23/2019(3)

02/23/2019(3)

Common Stock

43,724

$21.03

Stock Appreciation Rights

02/28/2013(2)

02/28/2013(2)

Common Stock

23,135

$22.55

Explanation of Responses:

1. These options are fully exercisable.

2. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

3. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Remarks:

poajy12.htm

Lawrence A. Fox, by power of atty., for John D. Young

06/08/2012

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,

see

Instruction

(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations

See

18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,

see

Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.